San Diego, CA | May 6-9, 2015
news & highlights
The Society for Cardiovascular Angiography and Interventions
SCAI 2015 Hildner Lecture Provides
Glimpse Into Current and Future State
of Clinical Research
Simplifying large trials and investing in the next generation of clinical researchers are among the ways quality clinical research will be propagated in the years ahead,
according to Robert Harrington, MD, FSCAI, of Stanford University School of
Medicine. Dr. Harrington delivered the SCAI 2015 Hildner Lecture and addressed the
realities, challenges and opportunities in clinical research today.
THE ONUS ON INTERVENTIONAL CARDIOLOGY
Dr. Harrington began by exploring how quality and accountability are currently at
the heart of healthcare reform.
“The way that policy is being made, the way reimbursement is being decided, all
of these issues are key to a notion of accountability and quality,” Dr. Harrington said.
“Despite this emphasis on quality and the need for evidence to guide quality care, I
would submit to you that the data tell us that much of contemporary medicine has a low
quality of evidence guiding clinical decision-making. We need more evidence and we
need interventional cardiologists to help lead in this area.”
Dr. Harrington added that there is and has been a spirit of innovation and a culture
of research in interventional cardiology.
CONTINUED ON PAGE 23
Distribution of this independent report
is supported by
IN THIS ISSUE...
REAL CASES, REAL PRACTICE,
BETTER DECISION MAKING
New SCAI Course
Picks Up Where
Data Leave Off
SCAI’s newest educational program will bring interventional cardiologists
together for a program that combines
case-based learning and simulation with
the latest engaging educational strategies
to help physicians expand their expertise in
treatment of peripheral vascular disease, a
field where guidelines and data are limited.
The SCAI Complex Peripheral Vascular
Interventions Course (SCAI CPVI), to
be held Sept. 25–26, 2015, in Washington,
DC, will focus on clinical decision making
as well as patient and device selection for
revascularization of patients with lower-extremity vascular disease.
“This course fulfills an unmet need for clinicians in the field,” says Program Co-director
Sahil Parikh, MD, FSCAI. “Practitioners are
thirsting for more education and knowledge
on how to provide optimal treatment to the
growing number of patients with complex
peripheral vascular disease and critical limb
SCAI has already taken the lead in this
effort by developing a series of
expert consensus documents
CONTINUED ON PAGE 41
SCAI NWSLTR_Summer2015_FINAL.indd 1
8/14/15 1:22 PM